A citation-based method for searching scientific literature

Alex Mejia, Stephanie Schulz, Terry Hyslop, David S Weinberg, Scott A Waldman. Expert Rev Mol Diagn 2009
Times Cited: 10







List of co-cited articles
165 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.
Scott A Waldman, Terry Hyslop, Stephanie Schulz, Alan Barkun, Karl Nielsen, Janis Haaf, Christine Bonaccorso, Yanyan Li, David S Weinberg. JAMA 2009
83
80

Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
S L Carrithers, M T Barber, S Biswas, S J Parkinson, P K Park, S D Goldstein, S A Waldman. Proc Natl Acad Sci U S A 1996
177
70

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.
Daniel G Nicastri, John T Doucette, Tony E Godfrey, Steven J Hughes. J Mol Diagn 2007
85
70

A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
Stephanie Schulz, Terry Hyslop, Janis Haaf, Christine Bonaccorso, Karl Nielsen, Matthew E Witek, Ruth Birbe, Juan Palazzo, David Weinberg, Scott A Waldman. Clin Cancer Res 2006
64
70

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
B Cagir, A Gelmann, J Park, T Fava, A Tankelevitch, E W Bittner, E J Weaver, J P Palazzo, D Weinberg, R D Fry,[...]. Ann Intern Med 1999
97
70

Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.
S A Waldman, B Cagir, J Rakinic, R D Fry, S D Goldstein, G Isenberg, M Barber, S Biswas, C Minimo, J Palazzo,[...]. Dis Colon Rectum 1998
78
60


Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
Ruth Birbe, Juan P Palazzo, Rhonda Walters, David Weinberg, Stephanie Schulz, Scott A Waldman. Hum Pathol 2005
91
60

The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.
Jieru Egeria Lin, Peng Li, Adam Eugene Snook, Stephanie Schulz, Abhijit Dasgupta, Terry Marie Hyslop, Ahmara Vivian Gibbons, Glen Marszlowicz, Giovanni Mario Pitari, Scott Arthur Waldman. Gastroenterology 2010
79
60

Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
K Shailubhai, H H Yu, K Karunanandaa, J Y Wang, S L Eber, Y Wang, N S Joo, H D Kim, B W Miedema, S Z Abbas,[...]. Cancer Res 2000
169
60

Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine.
Peng Li, Jieru E Lin, Inna Chervoneva, Stephanie Schulz, Scott A Waldman, Giovanni M Pitari. Am J Pathol 2007
85
60

Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Peng Li, Stephanie Schulz, Alessandro Bombonati, Juan P Palazzo, Terry M Hyslop, Yihuan Xu, Amy A Baran, Linda D Siracusa, Giovanni M Pitari, Scott A Waldman. Gastroenterology 2007
101
60

Micrometastases and survival in stage II colorectal cancer.
G J Liefers, A M Cleton-Jansen, C J van de Velde, J Hermans, J H van Krieken, C J Cornelisse, R A Tollenaar. N Engl J Med 1998
524
60

Comparison of histopathology and RT-qPCR amplification of guanylyl cyclase C for detection of colon cancer metastases in lymph nodes.
Jean-François Haince, Michel Houde, Guillaume Beaudry, Sylvain L'espérance, Geneviève Garon, Marie Desaulniers, Laurie J Hafer, James I Heald, Stephen Lyle, Steven R Grossman,[...]. J Clin Pathol 2010
29
60

Bacterial enterotoxins are associated with resistance to colon cancer.
G M Pitari, L V Zingman, D M Hodgson, A E Alekseev, S Kazerounian, M Bienengraeber, G Hajnóczky, A Terzic, S A Waldman. Proc Natl Acad Sci U S A 2003
115
50

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
Glen S Frick, Giovanni M Pitari, David S Weinberg, Terry Hyslop, Stephanie Schulz, Scott A Waldman. Expert Rev Mol Diagn 2005
50
50

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
Richard Gray, Jennifer Barnwell, Christopher McConkey, Robert K Hills, Norman S Williams, David J Kerr. Lancet 2007
833
50

Guanylin mRNA expression in human intestine and colorectal adenocarcinoma.
M B Cohen, J A Hawkins, D P Witte. Lab Invest 1998
73
50

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Al B Benson, Deborah Schrag, Mark R Somerfield, Alfred M Cohen, Alvaro T Figueredo, Patrick J Flynn, Monika K Krzyzanowska, Jean Maroun, Pamela McAllister, Eric Van Cutsem,[...]. J Clin Oncol 2004
959
50

Expression of guanylin is downregulated in mouse and human intestinal adenomas.
K A Steinbrecher, T M Tuohy, K Heppner Goss, M C Scott, D P Witte, J Groden, M B Cohen. Biochem Biophys Res Commun 2000
66
50

Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation.
Kris A Steinbrecher, Steve A Wowk, Jeffrey A Rudolph, David P Witte, Mitchell B Cohen. Am J Pathol 2002
84
50

Guanylyl cyclase is a heat-stable enterotoxin receptor.
S Schulz, C K Green, P S Yuen, D L Garbers. Cell 1990
525
50

Guanylyl cyclases and signaling by cyclic GMP.
K A Lucas, G M Pitari, S Kazerounian, I Ruiz-Stewart, J Park, S Schulz, K P Chepenik, S A Waldman. Pharmacol Rev 2000
903
50

Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
Martin Beaulieu, Marie Desaulniers, Nicolas Bertrand, Réna G Deschesnes, Guillaume Beaudry, Geneviève Garon, Jean-François Haince, Michel Houde, Timothy J Holzer. Diagn Mol Pathol 2010
19
50

Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
Daniel J Sargent, Murray B Resnick, Michael O Meyers, Atoussa Goldar-Najafi, Thomas Clancy, Sharlene Gill, Gary O Siemons, Qian Shi, Brian M Bot, Tsung-Teh Wu,[...]. Ann Surg Oncol 2011
23
50

Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Anton J Bilchik, Dave S B Hoon, Sukamal Saha, Roderick R Turner, David Wiese, Maggie DiNome, Kazuo Koyanagi, Martin McCarter, Perry Shen, Douglas Iddings,[...]. Ann Surg 2007
113
40

The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas.
Matthew E Witek, Karl Nielsen, Rhonda Walters, Terry Hyslop, Juan Palazzo, Stephanie Schulz, Scott A Waldman. Clin Cancer Res 2005
69
40

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
40


Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
Stephen L Carrithers, Cobern E Ott, Michael J Hill, Brett R Johnson, Weiyan Cai, Jason J Chang, Rajesh G Shah, Congmei Sun, Elizabeth A Mann, Manasses C Fonteles,[...]. Kidney Int 2004
71
40

The staging of colorectal cancer: 2004 and beyond.
Carolyn C Compton, Frederick L Greene. CA Cancer J Clin 2004
296
40


Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.
G M Pitari, M D Di Guglielmo, J Park, S Schulz, S A Waldman. Proc Natl Acad Sci U S A 2001
125
40

Escherichia coli heat-stable toxin receptors in human colonic tumors.
S L Carrithers, S J Parkinson, S Goldstein, P Park, D C Robertson, S A Waldman. Gastroenterology 1994
80
40

Adjuvant treatment of colorectal cancer.
Brian M Wolpin, Jeffrey A Meyerhardt, Harvey J Mamon, Robert J Mayer. CA Cancer J Clin 2007
189
40

Colorectal cancer is a paracrine deficiency syndrome amenable to oral hormone replacement therapy.
P Li, J E Lin, A E Snook, A V Gibbons, D S Zuzga, S Schulz, G M Pitari, S A Waldman. Clin Transl Sci 2008
17
40

Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target.
Jieru E Lin, Peng Li, Giovanni M Pitari, Stephanie Schulz, Scott A Waldman. Future Oncol 2009
19
40

The paracrine hormone hypothesis of colorectal cancer.
G M Pitari, P Li, J E Lin, D Zuzga, A V Gibbons, A E Snook, S Schulz, S A Waldman. Clin Pharmacol Ther 2007
44
40


Interruption of homologous desensitization in cyclic guanosine 3',5'-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins.
Giovanni M Pitari, Ronnie I Baksh, David M Harris, Peng Li, Shiva Kazerounian, Scott A Waldman. Cancer Res 2005
32
40


Gene expression in colorectal cancer.
Karin Birkenkamp-Demtroder, Lise Lotte Christensen, Sanne Harder Olesen, Casper M Frederiksen, Päivi Laiho, Lauri A Aaltonen, Søren Laurberg, Flemming B Sørensen, Rikke Hagemann, Torben F ØRntoft. Cancer Res 2002
200
40

Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli.
J M Hughes, F Murad, B Chang, R L Guerrant. Nature 1978
349
40

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf, Matilde Navarro, Josep Tabernero, Tamas Hickish, Clare Topham, Marta Zaninelli, Philip Clingan, John Bridgewater,[...]. N Engl J Med 2004
40

Systemic therapy for colorectal cancer.
Jeffrey A Meyerhardt, Robert J Mayer. N Engl J Med 2005
827
40

The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined.
Richard S Swanson, Carolyn C Compton, Andrew K Stewart, Kirby I Bland. Ann Surg Oncol 2003
447
30

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.
Carmen J Allegra, J Milburn Jessup, Mark R Somerfield, Stanley R Hamilton, Elizabeth H Hammond, Daniel F Hayes, Pamela K McAllister, Roscoe F Morton, Richard L Schilsky. J Clin Oncol 2009
896
30

Effective surgical adjuvant therapy for high-risk rectal carcinoma.
J E Krook, C G Moertel, L L Gunderson, H S Wieand, R T Collins, R W Beart, T P Kubista, M A Poon, W C Meyers, J A Mailliard. N Engl J Med 1991
30

Targeted agents for adjuvant therapy of colon cancer.
Aimery de Gramont, Christophe Tournigand, Thierry André, Annette K Larsen, Christophe Louvet. Semin Oncol 2006
21
30

Adjuvant therapy for stage II and III colorectal cancer.
Aimery de Gramont, Christophe Tournigand, Thierry André, Annette K Larsen, Christophe Louvet. Semin Oncol 2007
25
30


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.